Long-term outcome of autologous stem cell transplantation in light chain deposition disease

Nephrology Dialysis Transplantation

Volumn 23, Issue 6, 2008, Pages 2052-2057

  Lorenz, Elizabeth C ^a   Gertz, Morie A ^a   Fervenza, Fernando C ^a   Dispenzieri, Angela ^a   Lacy, Martha Q ^a   Hayman, Suzanne R ^a   Gastineau, Dennis A ^a   Leung, Nelson ^a  

^a MAYO CLINIC   (United States)

Author keywords

Light chain deposition disease; Monoclonal gammopathy; Paraproteinemia; Renal dysfunction; Stem cell transplantation

Indexed keywords

CREATININE; DEXAMETHASONE; LENALIDOMIDE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THALIDOMIDE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIGHT CHAIN DEPOSITION DISEASE; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION; SYSTEMIC DISEASE;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 44449101706     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm918     Document Type: Article

References (17)

1. Sanders PW, Herrera GA. Monoclonal immunoglobulin light chain-related renal diseases. Semin Nephrol 1993; 13: 324-341
2. Preud'Homme JL, Ganeval D, Grunfeld JP et al. Immunoglobulin synthesis in primary and myeloma amyloidosis. Clin Exp Immunol 1988; 73: 389-394
3. Heilman RL, Velosa JA, Holley KE et al. Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. Am J Kidney Dis 1992; 20: 34-41
4. Ronco PM, Alyanakian MA, Mougenout B et al. Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol 2001; 12: 1558-1565
5. Pozzi C, D'Amico M, Fogazzi GB et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 2003; 42: 1154-1163
6. Colombat M, Stern M, Groussard O et al. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med 2006; 173: 777-780
7. Leung N, Lager DJ, Gertz MA et al. Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis 2004; 43: 147-153
8. Pirani CL, Silva F, D'Agati VD et al. Renal lesions in plasma cell dyscrasias: ultrastructural observations. Am J Kidney Dis 1987; 10: 208-221
9. Ganeval D, Noel LH, Preud'Homme JL et al. Light-chain deposition disease: its relation with AL-type amyloidosis. Kidney Int 1984; 26: 1-9
10. Komatsuda A, Wakui H, Ohtani H et al. Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy. Am J Kidney Dis 2000; 35: E9
11. Weichman K, Dember LM, Prokaeva T et al. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatmentwith high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant 2006; 38: 339-343
12. Mariette X, Clauvel JP, Brouet JC. Intensive therapy in AL amyloidosis and light-chain deposition disease. Ann Intern Med 1995; 123: 553
13. Firkin F, Hill PA, Dwyer K et al. Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation. Am J Kidney Dis 2004; 44: 551-555
14. Kyle R, Rajkumar SV. Multiple myeloma. N Engl J Med 2004; 351: 1860-1873
15. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
16. Gertz MA, Lacy MQ, Gastineau DA et al. Blood cell transplantation as therapy for primary systemic amyloidosis. Bone Marrow Transplant 2000; 26: 963-969
17. Royer B, Arnulf B, Martinez F et al. High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int 2004; 65: 642-648